Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active Metabolite
Clinical trial NCT04902105 · COMPLETED
Trial details
- NCT number
- NCT04902105
- Sponsor
- Emalex Biosciences Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-13
- Primary completion
- 2021-07-06
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.